1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Iverson, H.A. Fox, D. Nadler, L.S. Klevit, R.E. Nathanson, N.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 280 24568 24575 10.1074/jbc.M501264200 15870063 Identification and structural determination of the M3 muscarinic acetylcholine receptor basolateral sorting signal. 2005 10.2210/pdb2csa/pdb pdb_00002csa 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 1995.024 Muscarinic acetylcholine receptor M3 THIRD INTRACELLULAR LOOP (Residues:271-289) 1 syn polymer no no SGTEAETENFVHPTGSSRS SGTEAETENFVHPTGSSRS A polypeptide(L) n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2005-05-31 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name RCSB Y RCSB 2005-05-21 REL REL The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human). sample NOESY spectra were collected with a mixing time of 300ms structures with the lowest energy 200 10 2D TOCSY 2D TOCSY 2D NOESY 2D NOESY 2D NOESY 2D NOESY 2D NOESY 2D NOESY DQF-COSY 6.4 ambient 285 K 6.4 ambient 278 K 6.4 ambient 288 K 6.4 ambient 298 K 6.4 ambient 308 K 6.4 ambient 318 K Structures are based on a total of 58 inter-residue NOE distance restraints and 5 dihedral angle restraints Distance Geometry, Simulated Annealing, Energy minimization 1 lowest energy 1-2mM M3 peptide, unlabeled, 50mM sodium phosphate buffer, 1mM EDTA, 1mM NaN3, 90% H2O, 10% D20 90% H2O, 10% D20 1-2mM M3 peptide, unlabeled, 50mM sodium phosphate buffer, 1mM EDTA, 1mM NaN3, 99.9 % D20, 0.1% H20 99.9 % D20, 0.1% H20 Bruker collection XwinNMR 2.6 Delaglio processing NMRPipe Delaglio data analysis NMRView 5 Brunger refinement CNS 1.1 500 Bruker DMX SER 1 n 1 SER 1 A GLY 2 n 2 GLY 2 A THR 3 n 3 THR 3 A GLU 4 n 4 GLU 4 A ALA 5 n 5 ALA 5 A GLU 6 n 6 GLU 6 A THR 7 n 7 THR 7 A GLU 8 n 8 GLU 8 A ASN 9 n 9 ASN 9 A PHE 10 n 10 PHE 10 A VAL 11 n 11 VAL 11 A HIS 12 n 12 HIS 12 A PRO 13 n 13 PRO 13 A THR 14 n 14 THR 14 A GLY 15 n 15 GLY 15 A SER 16 n 16 SER 16 A SER 17 n 17 SER 17 A ARG 18 n 18 ARG 18 A SER 19 n 19 SER 19 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A THR 3 63.73 129.30 1 A GLU 4 -149.99 -47.13 1 A ALA 5 -59.31 -167.18 1 A THR 7 -172.52 -41.92 1 A ASN 9 -173.60 100.38 1 A PHE 10 -147.88 -52.23 1 A VAL 11 -151.06 -46.89 1 A SER 17 -60.38 -74.54 1 A ARG 18 -108.99 -69.92 2 A GLU 4 -160.57 -51.86 2 A ALA 5 -84.68 -78.70 2 A GLU 6 -90.09 52.51 2 A THR 7 -161.19 81.76 2 A ASN 9 60.50 100.43 2 A PHE 10 -152.41 -52.10 2 A VAL 11 -150.93 -46.91 3 A GLU 4 -149.98 -47.18 3 A ALA 5 -59.99 -70.14 3 A GLU 6 -86.18 -77.32 3 A THR 7 60.57 92.25 3 A PHE 10 -127.89 -53.22 3 A VAL 11 -152.03 -46.69 3 A THR 14 -57.71 -178.12 4 A THR 3 60.58 110.66 4 A GLU 4 -159.93 31.59 4 A THR 7 -168.96 80.09 4 A PHE 10 -129.88 -51.51 4 A VAL 11 -153.62 -45.28 4 A SER 17 -176.40 -170.09 5 A THR 3 60.43 87.98 5 A GLU 4 -152.24 31.67 5 A ASN 9 -179.18 86.44 5 A PHE 10 -135.04 -57.81 5 A VAL 11 -155.50 -45.71 5 A ARG 18 -166.98 105.09 6 A THR 3 -163.77 95.05 6 A GLU 4 -150.52 31.76 6 A ALA 5 -89.67 -79.36 6 A THR 7 60.52 97.96 6 A PHE 10 -95.45 -85.43 6 A VAL 11 -155.89 -68.56 6 A SER 16 -171.39 35.45 7 A THR 3 56.95 104.96 7 A THR 7 -158.34 84.44 7 A ASN 9 60.54 80.63 7 A PHE 10 -73.92 -85.19 7 A VAL 11 -154.28 -53.37 7 A HIS 12 178.35 -52.06 7 A THR 14 -54.54 179.37 7 A SER 16 -170.03 124.71 7 A ARG 18 60.51 89.58 8 A THR 3 68.35 -68.99 8 A GLU 4 -176.51 -67.44 8 A ASN 9 -170.23 99.40 8 A PHE 10 -109.82 -85.58 8 A VAL 11 -155.88 -69.42 8 A SER 17 -65.17 95.06 9 A PHE 10 -121.62 -54.60 9 A VAL 11 -152.71 -58.42 9 A ARG 18 60.65 157.96 10 A THR 3 -105.50 -72.35 10 A GLU 4 -179.93 130.36 10 A GLU 6 -90.10 51.50 10 A ASN 9 -176.80 99.91 10 A PHE 10 -107.38 -70.52 10 A VAL 11 -178.28 -78.61 10 A SER 17 -159.25 31.62 Structure of the M3 Muscarinic Acetylcholine Receptor Basolateral Sorting Signal 1 N N Signaling Protein/MEMBRANE PROTEIN BASOLATERAL SORTING-SIGNAL BLSS BETA-TURN, Signaling Protein-MEMBRANE PROTEIN COMPLEX ACM3_HUMAN UNP 1 271 P20309 SGTEAETENFVHPTGSSRS 271 289 2CSA 1 19 P20309 A 1 1 19